Matthew W. McClure's Net Worth
$0
Who is Matthew W. McClure?
Matthew W. McClure does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Aligos Therapeutics, Inc..
SEC CIK
Matthew W. McClure's CIK is 0001927121
Past Insider Trading and Trends
2024 was Matthew W. McClure's most active year for acquiring shares with 4 total transactions. Matthew W. McClure's most active month to acquire stocks was the month of January. 2024 was Matthew W. McClure's most active year for disposing of shares, totalling 3 transactions. Matthew W. McClure's most active month to dispose stocks was the month of January. 2024 saw Matthew W. McClure paying a total of $0.00 for 229,324 shares, this is the most they've acquired in one year. In 2024 Matthew W. McClure cashed out on 370,626 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Aligos Therapeutics, Inc. (ALGS) Snapshot price: $14
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 27 - Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||